跳至主要内容
临床试验/CTRI/2023/09/057492
CTRI/2023/09/057492尚未招募2 期

A pilot clinical trial to evaluate the effectiveness of Linga chendooram in the management of Uthiravatha suronitham (Rheumatoid arthritis) - Nil

I0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Onset of arthritis after the age of 16 years
  • Positive for rheumatoid factor (RF)
  • Anti - CCP
  • Either an erythrocyte sedimentation rate (ESR) of greater than 30 mm/hr OR
  • C-reactive protein level greater than 1.0 mg/dl (normal less than 0.4)
  • Diagnosis of Uthira Vatha Suronitham, as defined by fulfilling at least more than two articular involvements
  • Morning stiffness
  • Willing to take study medication
  • Willing to follow diet restriction
  • Patients giving informed consent (Signed or oral witnessed, according to local regulations) before any Protocol specific
  • procedures.

排除标准

  • Uncontrolled Diabetes Mellitus
  • Uncontrolled Hypertension
  • Cardiac disease
  • Renal disease
  • Neurological disorders
  • Pregnancy and lactation
  • History of alcohol or substance abuse
  • Active infection, or chronic or persistent infection that might
  • worsen with immunosuppressive treatment
  • Patients who have already participated in a new drug study in
  • the past 3 months

研究者

发起方
I

相似试验

Clinical Study to evaluate the effectiveness of... | 临床试验